CN Patent

CN101580501B — 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体

Assigned to Nanjing Cavendish Bio Engineering Technology Co Ltd · Expires 2011-03-09 · 15y expired

What this patent protects

本发明公开了一种3-(取代二氢异吲哚酮-2-基)-2，6-哌啶二酮的合成方法及其中间体，即式(I)化合物的合成方法，各取代基的定义详见说明书。本方法具有产率高、对环境影响小、原料易得等优点，适于工业化生产。

USPTO Abstract

本发明公开了一种3-(取代二氢异吲哚酮-2-基)-2，6-哌啶二酮的合成方法及其中间体，即式(I)化合物的合成方法，各取代基的定义详见说明书。本方法具有产率高、对环境影响小、原料易得等优点，适于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN101580501B
Jurisdiction
CN
Classification
—
Expires
2011-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Cavendish Bio Engineering Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.